Stocks and securities in focus
Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y ▼ |
---|---|---|---|---|---|---|---|
Novavax Inc. | -0.730% | 8.139% | 270.487% | 110.095% | 216.013% | -88.577% | 165.375% |
Ocular Therapeutix Inc. | -1.350% | -6.013% | 20.541% | -8.459% | 27.407% | -55.450% | 120.909% |
AbbVie Inc. | -0.430% | -4.773% | -2.961% | 12.980% | 3.383% | 57.315% | 101.980% |
Anavex Life Sciences Corp | 3.230% | -9.848% | 14.886% | -57.065% | -57.461% | -62.925% | 6.006% |
Biogen Inc. | 0.400% | -5.722% | 2.919% | -27.802% | -14.758% | -8.303% | -1.927% |
Cardiff Oncology Inc. | 0.160% | -5.224% | -16.776% | 102.487% | 141.261% | -50.775% | -9.286% |
Bristol-Myers Squibb | 0.840% | -4.765% | -8.707% | -35.681% | -17.522% | -28.879% | -9.538% |
Insmed Inc. | -4.720% | -11.404% | -12.174% | 17.442% | -29.371% | 3.061% | -13.081% |
Savara Inc. | -1.600% | -9.314% | -9.756% | 51.639% | -14.352% | 160.563% | -62.941% |
Thermogenesis Holdings Inc. | -0.950% | 2.970% | -13.333% | -57.377% | -8.772% | -99.450% | -99.484% |
SELLAS Life Sciences Group Inc | -2.180% | -3.582% | -5.000% | -12.585% | 32.513% | -85.293% | -99.648% |
Viking Therapeutics Inc | 1.620% | -5.668% | -15.639% | 194.891% | 235.030% | 1254.764% | - |
ImmunityBio Inc. | -0.170% | -7.319% | -13.691% | 148.992% | 25.551% | -57.422% | - |
Cytomx Therapeutics Inc | 1.980% | -7.771% | 8.400% | 1.119% | 16.476% | -75.840% | - |
R1 RCM Inc. | - | 1.786% | 4.587% | -22.449% | 16.327% | -39.037% | - |
NanoVibronix Inc. | 2.990% | 3.759% | 0.730% | -80.618% | -34.906% | - | - |
Verastem Inc. | 9.570% | -62.075% | -53.256% | -64.606% | -46.755% | -89.793% | - |
Fate Therapeutics Inc. | -2.580% | -9.405% | -8.204% | -30.958% | -8.436% | -94.807% | - |
Sintx Technologies Inc. | -16.890% | -41.132% | 64.644% | -95.163% | -82.472% | -99.950% | - |
Varian Medical Systems Inc. | - | - | - | - | - | - | - |